Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Comment] Are we ready for targeted therapy for IgA nephropathy?

Almost 50 years have passed since the initial description of IgA nephropathy by Berger and Hinglais.1 IgA nephropathy is the most common chronic glomerulonephritis in the world.2 A renal biopsy is required for diagnosis but not regularly performed early in the course of the disease in some regions.3 Clearly, many people with this disease go undiagnosed, as shown by marked differences in population-based incidences for European and North American cohorts.4 Variation exists even within a single country, as evidenced by 70% more kidney biopsies being performed in the Tayside region of Scotland compared with Greater Glasgow.

email